Jillian Gentile is a notable inventor based in the United States. She has made significant contributions to the field of biochemistry, particularly in the development of antibody formulations. Her work focuses on creating stable solutions that can be used in the treatment of complement-associated disorders.

Latest Patents

Jillian Gentile holds a patent for "High Concentration Anti-C5 Antibody Formulations." This patent relates to stable aqueous solutions comprising a high concentration of an anti-C5 antibody, such as ravulizumab. The disclosure outlines methods for preparing these solutions and their applications in treating or preventing disorders like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Career Highlights

Throughout her career, Jillian has focused on innovative approaches to antibody formulation. Her research has the potential to improve treatment options for patients suffering from serious health conditions. Although she currently has 2 patents, her work is recognized for its impact on therapeutic advancements.

Collaborations

Jillian has collaborated with esteemed colleagues, including Stephan Ortiz and Leena Philominathan. These partnerships have contributed to the development of her innovative solutions and have enhanced the research environment in which she operates.

Conclusion

Jillian Gentile is an influential figure in the field of biochemistry, particularly in the development of anti-C5 antibody formulations. Her work holds promise for improving treatment options for patients with complement-associated disorders.

This text is generated by artificial intelligence and may not be accurate.